Inventor · disambiguated record
Jason A. Carlyon
Also filed as: CARLYON JASON · CARLYON JASON A
11 granted patents·2 pending applications·37 citations·filing 2013–2022
88Inventor score
Files withUNIV VIRGINIA COMMONWEALTH13
Top patents by PatentIndex Score
13 records- 0191US9945851B2OmpA in vaccine compositions and as diagnostic targetsUNIV VIRGINIA COMMONWEALTH·Filed 2017·Granted Apr 17, 2018·5 cites·13 claims
- 0290US10086058B2AIPA, OMPA, and ASP14 in vaccine compositions and diagnostic targets for anaplasma phagocytophilum infectionUNIV VIRGINIA COMMONWEALTH·Filed 2015·Granted Oct 2, 2018·4 cites·4 claims
- 0389US11273213B2Chimeric vaccine antigens for anaplasmosisUNIV VIRGINIA COMMONWEALTH·Filed 2019·Granted Mar 15, 2022·3 cites·9 claims
- 0489US10039815B2OmpA and Asp14 in vaccine compositions and as diagnostic targetsUNIV VIRGINIA COMMONWEALTH·Filed 2017·Granted Aug 7, 2018·6 cites·9 claims
- 0588US10376570B2OmpA and ASP14 in vaccine compositions and as diagnostic targetsUNIV VIRGINIA COMMONWEALTH·Filed 2018·Granted Aug 13, 2019·5 cites·5 claims
- 0688US9248174B2OMPA and ASP14 in vaccine compositions and as diagnostic targetsUNIV VIRGINIA COMMONWEALTH·Filed 2013·Granted Feb 2, 2016·10 cites·7 claims
- 0786US10495639B2OmpA in vaccine compositions and as diagnostic targetsUNIV VIRGINIA COMMONWEALTH·Filed 2018·Granted Dec 3, 2019·2 cites·5 claims
- 0885US10736951B2OmpA and Asp14 in vaccine compositions and as diagnostic targetsUNIV VIRGINIA COMMONWEALTH·Filed 2019·Granted Aug 11, 2020·1 cites·3 claims
- 0982US10842860B2AipA, OmpA, and Asp14 in vaccine compositions and diagnostic targets for Anaplasma phagocytophilum infectionUNIV VIRGINIA COMMONWEALTH·Filed 2018·Granted Nov 24, 2020·1 cites·6 claims
- 1072US12239696B2Chimeric vaccine antigens for anaplasmosisUNIV VIRGINIA COMMONWEALTH·Filed 2022·Granted Mar 4, 2025·0 cites·2 claims
- 1171US11458197B2AipA, OmpA, and Asp14 in vaccine compositions and diagnostic targets for Anaplasma phagocytophilum infectionUNIV VIRGINIA COMMONWEALTH·Filed 2020·Granted Oct 4, 2022·0 cites·3 claims
- 1254US2016146811A1Ompa and asp14 in vaccine compositions and as diagnostic targetsUNIV VIRGINIA COMMONWEALTH·Filed 2015·Application pending·0 cites
- 1344US2019117753A1Ompa in vaccine compositions and as diagnostic targetsUNIV VIRGINIA COMMONWEALTH·Filed 2017·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →